Personalized Approach to Thyroid Disorders Part 2: Lectures

Our third of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.

Program Details

This course is available to watch on-demand and receive credit for up to one year from the date of webinar release. There is no live Q&A with faculty associated for this program. Registrants will be notified as new webinars in the series are released.

3.0 credits available until June 24, 2021. View the Accreditation Statement/Credit tab for details.

Personalized Approach to Thyroid Disorders Part 2: Lectures

Included in this webinar:

Thyroid Disorders in Pregnancy (Tim Korevaar)

Different TSH reference ranges according to ethnicity, BMI, other factors
Impact of autoimmunity in decision to treat
Newborn outcomes

Hypothyroidism After Thyroidectomy and Autoimmune: Do We Treat It Differently?

Thyroid hormone resistance: what is it and how to overcome it, and issues of thyroid hormone conversion and signaling (Douglas Forrest)
Addition of T3? (Anne R. Cappola)
Surgery as strategy to treat autoimmune thyroid disease, eliminate TPO Abs, and quality of life issues (Rebecca S. Sippel)

Hyperthyroidism: Personalized Therapeutic Options According to Etiology and Patient Preference

RAI and risk of secondary malignancies (Cari Meinhold Kitahara)
Role of surgery: when and why (Sarah Oltmann)
Use of decision-aids in hyperthyroidism (Susan C. Pitt)

Initial Approach to Low Risk Thyroid Cancer

Use of decision-aids to proceed with active surveillance versus lobectomy versus total thyroidectomy (Reese W. Randle)
How does molecular testing help in thyroid nodules when combined with ultrasound characteristics? (Jennifer A. Sipos)

Approach to Advanced Thyroid Cancer

When not to operate in advanced thyroid cancer (Patrick Ha)
How does molecular testing inform extent of initial surgery in low risk and high-risk lesions? (Masha Livhits)
Molecular-based therapies and redifferentiation trials (Mabel M. Ryder)

Learning Objectives

Upon completion of this educational activity, learners will be able to:

Describe demographic factors that make clinicians evaluate pregnant patients for treatment of thyroid disorders.
Explain the indications, risks, and benefits of treating pregnant patients with thyroid disease.
Explain challenging scenarios in the treatment of patients with hypothyroidism after thyroidectomy and autoimmune hypothyroidism.
Understand the utility of decision-support tools to help patients and physicians discuss different treatment modalities in the management of hyperthyroidism and thyroid cancer.
Identify the specific scenarios in which molecular testing of tumors becomes informative and provides the basis for an individualized therapeutic strategy.

Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.

Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).